Major depression and antidepressant treatment: Impact on pregnancy and neonatal outcomes

American Journal of Psychiatry

Volumn 166, Issue 5, 2009, Pages 557-566

  Wisner, Katherine L ^a   Sit, Dorothy K Y ^b   Hanusa, Barbara H ^b   Moses Kolko, Eydie L ^b   Bogen, Debra L ^b   Hunker, Diane F ^b   Perel, James M ^b   Jones Ivy, Sonya ^b   Bodnar, Lisa M ^b   Singer, Lynn T ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; CONGENITAL MALFORMATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; OBSERVATIONAL STUDY; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; WEIGHT GAIN;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; APGAR SCORE; BIRTH WEIGHT; CHILD OF IMPAIRED PARENTS; DEPRESSIVE DISORDER, MAJOR; DISABLED CHILDREN; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; WEIGHT GAIN; YOUNG ADULT;

EID: 66149160394     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08081170     Document Type: Article

References (40)

1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National Comorbidity Survey Replication: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCSR). JAMA 2003; 289:3095-3105
2. Reefhuis J, Rasmussen SA, Friedman JM: Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn; reply of Chambers C, Hernandez-Diaz S, Mitchell AA (letter). N Engl J Med 2006; 354:2188-2190
3. Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, Ormond K, Matsui D, Stein-Schechman AK, Cook L, Brochu J, Rieder M, Koren G: Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998; 279:609-610 (Pubitemid 28110208)
4. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JG, Kulin N, Koren G: Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336:258-262 (Pubitemid 27044627)
5. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, Donnenfeld A, McCormack M, Leen-Mitchell M, Woodland C, et al: Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993; 269:2246-2248
6. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL: Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335:1010-1015 (Pubitemid 26338730)
7. Ericson A, Kallen B, Wiholm B: Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999; 55:503-508 (Pubitemid 29446550)
8. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM, National Birth Defects Prevention Study: Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007; 356:2684-2692 (Pubitemid 47001036)
9. Louik C, Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA: First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007; 356:2675-2683 (Pubitemid 47001035)
10. Greene MF: Teratogenicity of SSRIs-serious concern or much ado about little? (editorial). N Engl J Med 2007; 356:2732-2733 (Pubitemid 47001045)
11. Leppig KA, Werler MM, Cann CI, Cook CA, Holmes LB: Predictive value of minor anomalies, I: association with major malformations. J Pediatr 1987; 110:531-537
12. Waldrop MF, Pedersen FA, Bell RQ: Minor physical anomalies and behavior in preschool children. Child Dev 1968; 39:391-400
13. Chambers CD, Dick LM, Felix RJ, Johnson KA, Jones KL: Pregnancy outcomes in women who use sertraline (abstract). Teratology 1999; 59:376
14. Simon GE, Cunningham ML, Davis RL: Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002; 159:2055-2061 (Pubitemid 35423865)
15. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C: Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63:898-906 (Pubitemid 44188483)
16. Pearson KH, Nonacs RM, Viguera AC, Heller VL, Petrillo LF, Brandes M, Hennen J, Cohen LS: Birth outcomes following prenatal exposure to antidepressants. J Clin Psychiatry 2007; 68:1284-1289 (Pubitemid 47395633)
17. Lund N, Pedersen L, Henriksen T: SSRI exposure in utero and pregnancy outcome. J Matern Fetal Neonatal Med 2006; 19(5 suppl 1):45
18. Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J: Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007; 164:1206-1213 (Pubitemid 47292409)
19. Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C, Walker M: Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006; 194:961-966
20. Malm H, Klaukka T, Neuvonen PJ: Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005; 106:1289-1296 (Pubitemid 41668948)
21. Institute of Medicine: Preterm Birth: Causes, Consequences and Prevention. Washington, DC, National Academy Press, 2007
22. Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL: Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 293:2372-2383 (Pubitemid 40676760)
23. Laine K, Heikkinen T, Ekblad U, Kero P: Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003; 60:720-726 (Pubitemid 36818634)
24. Kallen B: Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004; 158:312-316 (Pubitemid 38451555)
25. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA: Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354:579-587 (Pubitemid 43209105)
26. Costei AM, Kozer E, Ho T, Ito S, Koren G: Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002; 156:1129-1132 (Pubitemid 36343460)
27. Wisner KL, Hanusa BH, Perel JM, Peindl KS, Piontek CM, Sit DK, Findling RL, Moses-Kolko EL: Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 2006; 26:353-360 (Pubitemid 44187636)
28. Post RM, Roy-Byrne PP, Uhde TW: Graphic representation of the life course of illness in patients with affective disorder (commentary). Am J Psychiatry 1988; 145:844-848 (Pubitemid 18169501)
29. Williams J, Terman M: Structured Interview Guide for the Hamilton Depression Rating Scale With Atypical Depression Supplement (SIGH-ADS). New York, New York State Psychiatric Institute, 2003
30. Ware JE, Kosinski M, Keller SD: A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34:220-233 (Pubitemid 126433231)
31. Day NL, Robles N, Richardson G, Geva D, Taylor P, Scher M, Stoffer D, Cornelius M, Goldschmidt L: The effects of prenatal alcohol use on the growth of children at 3 years of age. Alcohol Clin Exp Res 1991; 15:67-71
32. Institute of Medicine: Nutrition During Pregnancy. Washington, DC, National Academy Press, 1990
33. O'Hara M, Varner M, Johnson S: Assessing stressful life events associated with childbearing: the Peripartum Events Scale. J Reprod Infant Psychol 1986; 4:85-98
34. Misri S, Reebye P, Kendrick K, Carter D, Ryan D, Grunau RE, Oberlander TF: Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry 2006; 163:1026-1032 (Pubitemid 44464489)
35. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G: Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159:1889-1895 (Pubitemid 35283255)
36. Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE: Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003; 142:402-408 (Pubitemid 36521227)
37. Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D: Placental passage of antidepressant medications. Am J Psychiatry 2003; 160:993-996 (Pubitemid 41079587)
38. Cooper WO, Willy ME, Pont SJ, Ray WA: Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007; 196:544.e1-544.e5
39. Sanz EJ, de las Cuevas C, Kiuru A, Bate A, Edwards R: Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005; 365:482-487
40. Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G: Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160:173-176 (Pubitemid 43213863)